The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Infectious Disease & AMR

Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis
Clinical & Manufacturing

Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis

FEB 17, 2020
Finch Therapeutics Completes Enrollment in Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection
Clinical & Manufacturing

Finch Therapeutics Completes Enrollment in Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection

JAN 8, 2020
Beware probiotics in ICU patients
Infectious Disease & AMR

Beware probiotics in ICU patients

NOV 20, 2019
Unknown Virus Discovered in Human Body
Basic & Discovery Research

Unknown Virus Discovered in Human Body

NOV 13, 2019
Clostridium difficile infections may have a friend in fungi
Infectious Disease & AMR

Clostridium difficile infections may have a friend in fungi

AUG 29, 2019
Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
Finance

Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections

JUL 18, 2019
DuPont to Provide Probiotics for International Pediatric Sepsis Research
Infectious Disease & AMR

DuPont to Provide Probiotics for International Pediatric Sepsis Research

APR 26, 2019
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
Finance

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics

APR 1, 2019
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Clinical & Manufacturing

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

FEB 28, 2019
Bioharmony Therapeutics and Boehringer Ingelheim to Advance Bacteriophage Lysin Therapeutics
Finance

Bioharmony Therapeutics and Boehringer Ingelheim to Advance Bacteriophage Lysin Therapeutics

JAN 16, 2019
APT Enters into Collaboration Agreement with Yale University to Manufacture and Supply Therapeutic Bacteriophage
Infectious Disease & AMR

APT Enters into Collaboration Agreement with Yale University to Manufacture and Supply Therapeutic Bacteriophage

JAN 2, 2019